Deutsche Bank AG Releases Weekly Share Buyback Report as Part of PostAdmission Duties OpenAI Emerges as Frontrunner in AI IPO Race Amid Confidential Filing Plans US Retail Sales Growth Slows as Consumer Sentiment Dips on Labor Market Concerns US Benchmark Indices Hold Firm With Market Sentiment Remaining Upbeat Australian Taxpayer Subsidies and BHP Climate Retreat Raise Questions on Emission Goals Akamai Technologies Finalizes Convertible Senior Notes Offering CTEV Q1 2026 Earnings Significant EPS Miss Amidst Operational Challenges uCloudlink Group UCL Q1 2026 Earnings NarrowerThanExpected Loss Fails to Propel Stock Dream Finders Homes Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Intercorp Financial Services Inc IFS Q1 2026 Earnings EPS Surprise Lifts Results Despite Tepid Stock Reaction CHKP Q1 2026 Earnings Cybersecurity Leader Delivers Modest EPS Beat Shares Edge Higher Sensient Technologies Q1 2026 Earnings Strong EPS Beat Drives Stock Gain BNY Mellon Strategic Municipal Bond Fund DSM holds steady near support with minor uptick NRX Pharmaceuticals NRXP Surges 523 on Renewed Buying Interest Near Support Innovative Solutions and Support Inc ISSC Surges 456 as Momentum Builds Toward Key Resistance DXC Technology DXC Slips 137 as Shares Approach Key Support Level Goldman Sachs BDC GSBD Hovers Near Support as Dividend Appeal Offsets Tepid Volume Kevin Warsh Set to Assume Federal Reserve Chairmanship in White House Ceremony UCL Q1 2026 Earnings Narrower Loss Surprises Analysts as Shares Dip Lexaria Bioscience LEXX Surges 733 as Biotech Momentum Builds Key Levels in Focus SERV Q1 2026 Earnings EPS Misses on WiderThanExpected Loss ENPH Q1 2026 Earnings EPS Surprises to the Upside as Enphase Navigates Market Headwinds YDKG Q4 2012 Earnings EPS Misses Estimates Stock Edges Higher AEMD Q1 2026 Earnings EPS Beats Estimates by 075 Amid Revenue Absence Stock Declines 1596 CBIZ Inc CBZ Q1 2026 Earnings EPS Surges Past Estimates Amid Mixed Market Reaction DTE Energy Q1 2026 Earnings Earnings Miss Estimates as Costs Pressure Results CRNX Q1 2026 Earnings EPS Surprise Beats Estimates as PreRevenue Biotech Advances Pipeline